Recipharm, the leading contract development and manufacturing organization, is pleased to announce that it has appointed Yves Buelens to the position of General Manager for its wholly owned new subsidiary Kaysersberg Pharmaceuticals SAS.
Yves Buelens has a Master’s in Pharmaceutical Sciences from the University of Brussels, Belgium, and a specialization as an Industrial Pharmacist (QP). He brings a broad experience to the group acquired in various roles in the pharmaceutical industry, as well as in contract manufacturing organizations in Europe. Yves has been the plant manager for the Kaysersberg facility since 2014.
Commenting on the appointment, CEO Thomas Eldered, said: “Yves Buelens brings valuable experience to Recipharm having worked with a variety of pharmaceutical companies including CDMOs. I am sure he and his team will contribute greatly to the ongoing development of Recipharm and in particular with this exciting new technology.”
Yves Buelens said: “I’m looking forward to becoming a member of the Recipharm family. I believe it will be a fruitful environment for growth and expansion of the Kaysersberg site. The long-term contract with Alcon will be an excellent foundation and milestone for other business opportunities and the proven quality track record will be the cornerstone to attract new customers. Recipharm’s entrepreneurship, combined with the technical skills of the Alsace workforce, will give us a bright future together.”